Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,623.79
(
1.03%
)
US TECH 100
23,569.20
(
0.90%
)
Dow Jones
46,606.77
(
1.05%
)
Brent Oil
95.84
(
-0.69%
)
Bitcoin
71,780.99
(
1.79%
)
News Focus
News Focus
Post# of 257278
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122810
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 232866

Tuesday, 06/09/2020 10:18:32 PM

Tuesday, June 09, 2020 10:18:32 PM

Post# of 257278
Re: RVNC/Botox-biosimilar info from today’s GS webcast

RVNC is eligible to receive $60-70M from MYL in clinical/regulatory milestones and as much as $250M in sales-based milestones. (These amounts are in addition to the $60M RVNC has already received from MYL.)

As far as I know, today is the first time RVNC has disclosed any details about the clinical/regulatory and sales-based milestones in this program.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today